EU and UK approve Microbiome Medicines for advanced melanoma and ulcerative colitis

Source: BioPharma Reporter , August 2024

Microbiotica has received the green light from EU and UK regulatory authorities to start phase 1b studies for its microbiome medicines in advanced melanoma and ulcerative colitis.
READ THE ORIGINAL FULL ARTICLE